REGISTERED
on 23 Aug 2022
Last Applicant/ Owned by
7500 Rialto Blvd.
Austin
TX
78735
Serial Number
90252361 filed on 13th Oct 2020
Registration Number
6828530 registered on 23rd Aug 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
P HLA PROTEIN
Chemicals and biochemicals for in vitro clinical and medical use Reagents for scientific, pharmaceutical, clinical, and medical research purposes; laboratory chemicals, namely, protein-based reagents used for the detection of antibodies and receptors in cell, blood, and tissue analysis for in vitro diagnostics for scientific use and research in the field of therapeutic reagent designs; chemicals Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Providing scientific, pharmaceutical, clinical, and medical research information via the internet; research and development of new products; pharmaceutical drug and biomarker preparation target discovery, development, and validation in the nature of research, development, and quality assurance services; pharmaceutical and scientific research and development services; medical research services; medical development services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; clinical research services in the fields of pharmaceuticals, biology, chemistry, biochemistry, and clinical trials; clinical development services in the nature of scientific development of clinical trials; consulting services in the field of pharmaceutical assessment; scientific and medical research consulting services for transplant and organ rejection assessment; validation in the nature of quality assurance services, screening and mapping in the nature of scientific research and development of biological material for drug discovery and vaccine manufacturing purposes; providing scientific information and medical research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; scientific and medical research and development in the field of cancer, infectious diseases, autoimmune diseases and allergies; scientific and medical research and development in the field of antibody, B cell and T cell detection in transplant and organ rejection
First Use Date in General
21st Dec 2020
First Use Date in Commerce
21st Dec 2020
Class [005]
Pharmaceutical Products
Chemicals and biochemicals for in vitro clinical and medical use
First Use Date in General
04th Jan 2021
First Use Date in Commerce
04th Jan 2021
Class [001]
Chemical Products
Reagents for scientific, pharmaceutical, clinical, and medical research purposes; laboratory chemicals, namely, protein-based reagents used for the detection of antibodies and receptors in cell, blood, and tissue analysis for in vitro diagnostics for scientific use and research in the field of therapeutic reagent designs; chemicals and biochemicals in the nature of reactants and reagents for in vitro scientific or research use; chemicals and biochemicals for use in the manufacture of pharmaceutical preparations; chemical, biochemical and biotechnological solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with antibody and B or T cell detection, separation and labelling; biochemical reagents for detecting and analyzing molecules in protein arrays; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemical, biochemical and biotechnological products in the nature of reactants and reagents for use in biotechnological product development of therapeutics for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and allergies; chemical, biochemical and biotechnological preparations used in industry and science, and in the development and manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and allergies; chemical, biochemical and biotechnological preparations used in industry and science, and in the development and manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the detection, prevention and treatment of rejection causing antibodies, B and T cells
First Use Date in General
04th Jan 2021
First Use Date in Commerce
04th Jan 2021
Class [044]
Medical, Beauty & Agricultural Services
Medical consulting services for transplant and organ rejection assessment
First Use Date in General
21st Dec 2020
First Use Date in Commerce
21st Dec 2020
Mark Details
Serial Number
No 90252361
Mark Type
No Service Mark
Attorney Docket Number
No PPTEN.043T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
24.13.02 -
Cross, Greek (equal sized lines)
24.17.06 -
Plus symbol (+)
26.09.14 -
Three or more squares
26.09.21 -
Squares that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Aug 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Aug 2022 | REGISTERED-PRINCIPAL REGISTER |
| 16th Jul 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 15th Jul 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 23rd Jun 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 23rd Jun 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 03rd Jun 2022 | USE AMENDMENT FILED |
| 03rd Jun 2022 | TEAS STATEMENT OF USE RECEIVED |
| 03rd May 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Apr 2022 | SOU EXTENSION 1 GRANTED |